The inflammatory chemokines CCL2 and CCL5 in breast cancer

G Soria, A Ben-Baruch - Cancer letters, 2008 - Elsevier
A causal role was recently attributed to inflammation in many malignant diseases, including
breast cancer. The different inflammatory mediators that are involved in this disease include …

CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients

KB de Oliveira, RL Guembarovski, JMM Oda… - Cytokine, 2011 - Elsevier
The role of chemokines has been extensively analyzed both in cancer risk and tumor
progression. Among different cytokines, CXCR4 and its ligand CXCL12 have been recently …

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

J Zhang, L Patel, KJ Pienta - Cytokine & growth factor reviews, 2010 - Elsevier
CCL2 is a chemokine known to recruit monocytes and macrophages to sites of inflammation.
A growing body of research suggests CCL2 is progressively overexpressed in tumor beds …

Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer

TC Walser, S Rifat, X Ma, N Kundu, C Ward… - Cancer research, 2006 - AACR
Tumor cells aberrantly express chemokines and/or chemokine receptors, and some may
promote tumor growth and metastasis. We examined the expression and function of …

Inflammatory chemokines in cancer growth and progression

BJ Rollins - European journal of cancer, 2006 - Elsevier
Leukocyte infiltration is a cardinal feature of almost all cancers. Chemokines are generally
responsible for eliciting local accumulation of inflammatory cells and they appear to play the …

Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs

E Pradelli, B Karimdjee‐Soilihi… - … journal of cancer, 2009 - Wiley Online Library
Metastasis continues to be the leading cause of mortality for patients with cancer. Several
years ago, it became clear that chemokines and their receptors could control the tumor …

CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model

X Sun, DJ Glynn, LJ Hodson, C Huo, K Britt… - Breast Cancer …, 2017 - Springer
Background Macrophages play diverse roles in mammary gland development and breast
cancer. CC-chemokine ligand 2 (CCL2) is an inflammatory cytokine that recruits …

Loss of transforming growth factor-β signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage …

SL Hembruff, I Jokar, L Yang, N Cheng - Neoplasia, 2010 - Elsevier
Whereas the accumulation of fibroblasts and macrophages in breast cancer is a well-
documented phenomenon and correlates with metastatic disease, the functional …

Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions

G Soria, N Yaal-Hahoshen, E Azenshtein, S Shina… - Cytokine, 2008 - Elsevier
The chemokines RANTES (CCL5) and MCP-1 (CCL2) were suggested to contribute,
independently, to breast malignancy. In the present study, we asked if the two chemokines …

The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease …

R Colobran, R Pujol-Borrell… - Clinical & …, 2007 - academic.oup.com
In this second review on chemokines, we focus on the polymorphisms and alternative
splicings and on their consequences in disease. Because chemokines are key mediators in …